Signal Bay Reports Q3 2017 Results

TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Signal Bay, Inc. (SGBY), a leading provider of quality control testing and advisory services to the regulated cannabis industry, reported financial results for the quarter ended June 30, 2017. 

Signal Bay’s Q3 2017 revenue was $777,218, up 566% compared to Q3 2016. Through nine months ended June 30, 2017, Signal Bay has recognized $2.28M, compared to $391K for the same period in the year prior, resulting in an annual year over year increase of 482%.   

Signal Bay’s Q3 2017 testing revenues remained relatively unchanged at a 3% increase compared to the prior quarter.  Whereas we saw a decline of 89% in consulting revenues compared to the prior quarter to $9,345.  

Executive Commentary 

“During our third quarter, we continued to see a strong demand for EVIO Labs testing services.  However, there were few opportunities to provide advisory services for new state applications during the quarter.” commented Signal Bay CEO William Waldrop, “Furthermore, we do foresee normal seasonality decrease during the fourth quarter as our customers begin to prepare for the fall harvest. This will be partially offset by revenue from our new lab in Massachusetts and licensee in Florida. On that note, the Oregon Liquor Control Commission announced the limited pesticide testing rule will expire on August 29, 2017, therefore starting on August 30th every batch of usable marijuana must be directly tested for pesticides.” 

COO Lori Glauser stated “Our advisory group which until very recently was focused on helping new entrepreneurs establish their businesses, has directed its attention towards internal projects, such as attaining state licensing and accreditation for new labs, mostly in California. We are also integrating newly acquired labs including centralizing administrative, sales, and marketing functions. For example, the company is in the final stages of implementing an EVIO-Wide Laboratory Information Management System (LIMS). This enterprise system will allow EVIO to consolidate and streamline many operational tasks, and enable us to work as a unified firm that can easily scale.”